Skip to main content
Clinical Trials/NCT01422551
NCT01422551
Completed
Phase 2

Facilitating Positive Adaptation to Breast Cancer

University of Miami1 site in 1 country240 target enrollmentSeptember 1999
ConditionsBreast Cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
University of Miami
Enrollment
240
Locations
1
Primary Endpoint
change from baseline to 12 month follow-up in psychosocial adaptation (less negative affect and social disruption; more benefit finding and positive affect)
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this study is to test the effects of a 10-wk cognitive behavioral stress management (CBSM) intervention vs. a single-day psycho-educational seminar on psychosocial adaptation and physiological adaptation in women being treated for stage I-III breast cancer.

Detailed Description

The study tests the effects of a 10-wk group-based cognitive behavioral stress management (CBSM) intervention (relaxation, stress awareness, cognitive restructuring, coping skills training, interpersonal skills training) versus a single-day psycho-educational seminar (general information about stress and coping) in women who have recently had surgery for breast cancer but have not yet started adjuvant therapy. The study evaluates the effects of CBSM on psychosocial adaptation (includes measures of negative adaptation \[distress and social disruption\] and positive adaptation \[benefit finding and positive affect\]) at 6-month and 12-month follow-up. The study also evaluates the effects of CBSM on physiological adaptation (includes levels of PM serum cortisol and T-helper-type 1 (Th1) cytokine \[interleukin-2, IL-2, and interferon-gamma, IFN-g, production after anti-CD3 stimulation of peripheral blood mononuclear cells (PBMC).

Registry
clinicaltrials.gov
Start Date
September 1999
End Date
August 2007
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael H. Antoni

Principle Investigator

University of Miami

Eligibility Criteria

Inclusion Criteria

  • women diagnosed with breast cancer at stage III or below who had recently undergone lumpectomy or mastectomy

Exclusion Criteria

  • prior cancer,
  • prior psychiatric treatment for a serious disorder (e.g., psychosis, suicidality),
  • lack of fluency in English and had begun adjuvant therapy at time of first assessment

Outcomes

Primary Outcomes

change from baseline to 12 month follow-up in psychosocial adaptation (less negative affect and social disruption; more benefit finding and positive affect)

Time Frame: baseline and 6 and 12 month follow-up

changes in a composite composed of negative affect measures plus a measure of social disruption plus a measure of benefit finding plus a measure of positive affect

Secondary Outcomes

  • change from baseline to 12 months in physiological adaptation (decreased serum cortisol and increased Th1 cytokine production)(baseline and 6 and 12 months follow-up)

Study Sites (1)

Loading locations...

Similar Trials